日本語 
Pharma
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Chugai Pharmaceutical to Acquire Renalys Pharma
Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys…
Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy
Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims…
Taiho Pharma Exercises Exclusive License for Casdatifan
Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…
Alpha Fusion and Kobe Hospital launch At-211 Drug system
Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…
Rentschler Biopharma Expands in Japan and Korea
Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…
Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer
Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…
Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery
Elix, Inc. and the Graduate School of Life Sciences at Tohoku University…
CM Plus launches “pharmo.AI” for pharma research support
CM Plus Co., Ltd. has officially released "pharmo.AI," an AI search system…
Chugai Pharmaceutical to Acquire Renalys Pharma
Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys…
Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy
Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims…
Taiho Pharma Exercises Exclusive License for Casdatifan
Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…
Alpha Fusion and Kobe Hospital launch At-211 Drug system
Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…
Rentschler Biopharma Expands in Japan and Korea
Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…
Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer
Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…
Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery
Elix, Inc. and the Graduate School of Life Sciences at Tohoku University…
CM Plus launches “pharmo.AI” for pharma research support
CM Plus Co., Ltd. has officially released "pharmo.AI," an AI search system…
English